Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.

Kasteleijn-Nolst Trenité DG, Biton V, French JA, Abou-Khalil B, Rosenfeld WE, Diventura B, Moore EL, Hetherington SV, Rigdon GC.

Epilepsia. 2013 Aug;54(8):1437-43. doi: 10.1111/epi.12224. Epub 2013 May 20.

2.

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility.

Hughes AR, Spreen WR, Mosteller M, Warren LL, Lai EH, Brothers CH, Cox C, Nelsen AJ, Hughes S, Thorborn DE, Stancil B, Hetherington SV, Burns DK, Roses AD.

Pharmacogenomics J. 2008 Dec;8(6):365-74. doi: 10.1038/tpj.2008.3. Epub 2008 Mar 11. Review.

PMID:
18332899
3.

Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants.

Capparelli EV, Bloom BT, Kueser TJ, Oelberg DG, Bifano EM, White RD, Schelonka RL, Pearlman SA, Patti J, Hetherington SV.

Antimicrob Agents Chemother. 2005 Oct;49(10):4121-7.

4.

Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.

Kessler HA, Johnson J, Follansbee S, Sension MG, Mildvan D, Sepulveda GE, Bellos NC, Hetherington SV.

Clin Infect Dis. 2002 Feb 15;34(4):535-42. Epub 2002 Jan 4.

PMID:
11797183
5.

The abacavir hypersensitivity reaction and interruptions in therapy.

Loeliger AE, Steel H, McGuirk S, Powell WS, Hetherington SV.

AIDS. 2001 Jul 6;15(10):1325-6. No abstract available.

PMID:
11426085
6.

Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.

Shenep JL, Flynn PM, Baker DK, Hetherington SV, Hudson MM, Hughes WT, Patrick CC, Roberson PK, Sandlund JT, Santana VM, Sixbey JW, Slobod KS.

Clin Infect Dis. 2001 Jan;32(1):36-43. Epub 2000 Dec 8.

PMID:
11112678
7.

Inter- and intra-patient sequence diversity among parainfluenza virus-type 1 nucleoprotein genes.

Dave VP, Hetherington SV, Portner A, Leggiadro RJ, Hurwitz JL.

Virus Genes. 1997;14(2):153-6.

PMID:
9237355
8.

Sequence and analysis of the rpoB gene of Mycobacterium smegmatis.

Hetherington SV, Watson AS, Patrick CC.

Antimicrob Agents Chemother. 1995 Sep;39(9):2164-6.

9.

Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.

Nahm MH, Kim KH, Anderson P, Hetherington SV, Park MK.

Infect Immun. 1995 Aug;63(8):2989-94.

10.

Molecular evolution of the F glycoprotein of human parainfluenza virus type 1.

Ambrose MR, Hetherington SV, Watson AS, Scroggs RA, Portner A.

J Infect Dis. 1995 Apr;171(4):851-6.

PMID:
7706810
11.

Comparative virulence of Staphylococcus epidermidis isolates in a murine catheter model.

Patrick CC, Hetherington SV, Roberson PK, Henwick S, Sloas MM.

Pediatr Res. 1995 Jan;37(1):70-4.

PMID:
7700736
12.

Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages.

Hetherington SV, Watson AS, Scroggs RA, Portner A.

J Infect Dis. 1994 Feb;169(2):248-52.

PMID:
7508966
13.

Monoclonal antibodies against a 97-kilodalton antigen from Aspergillus flavus.

Hetherington SV, Henwick S, Parham DM, Patrick CC.

Clin Diagn Lab Immunol. 1994 Jan;1(1):63-7.

14.
15.

Aspergillus terreus during hospital renovation.

Flynn PM, Williams BG, Hetherington SV, Williams BF, Giannini MA, Pearson TA.

Infect Control Hosp Epidemiol. 1993 Jul;14(7):363-5. No abstract available.

PMID:
8354865
16.

Complement binding to Aspergillus conidia correlates with pathogenicity.

Henwick S, Hetherington SV, Patrick CC.

J Lab Clin Med. 1993 Jul;122(1):27-35.

PMID:
8320488
17.

Specificity of three anti-complement factor 3 monoclonal antibodies.

Henwick S, Hetherington SV, Hostetter MK.

J Immunol Methods. 1992 Aug 30;153(1-2):173-84.

PMID:
1517587
18.

Correlation between antibody affinity and serum bactericidal activity in infants.

Hetherington SV, Lepow ML.

J Infect Dis. 1992 Apr;165(4):753-6.

PMID:
1552207
19.

Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections.

Patrick CC, Plaunt MR, Hetherington SV, May SM.

Infect Immun. 1992 Apr;60(4):1363-7.

21.

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men.

Hughes WT, Kennedy W, Shenep JL, Flynn PM, Hetherington SV, Fullen G, Lancaster DJ, Stein DS, Palte S, Rosenbaum D, et al.

J Infect Dis. 1991 Apr;163(4):843-8.

PMID:
2010637
22.
23.

Bacterial antigens and neutrophil granule proteins in middle ear effusions.

Miller MB, Koltai PJ, Hetherington SV.

Arch Otolaryngol Head Neck Surg. 1990 Mar;116(3):335-7.

PMID:
2306352
25.
26.
27.

Bacterial and polymorphonuclear leukocyte contribution to middle ear inflammation in chronic otitis media with effusion.

Giebink GS, Carlson BA, Hetherington SV, Hostetter MK, Le CT, Juhn SK.

Ann Otol Rhinol Laryngol. 1985 Jul-Aug;94(4 Pt 1):398-402.

PMID:
4040727
28.

Opsonic activity of immunoglobulin prepared for intravenous use.

Hetherington SV, Giebink GS.

J Lab Clin Med. 1984 Dec;104(6):977-86.

PMID:
6502004
29.

Patients with disorders of phagocytic cell function.

Quie PG, Hetherington SV.

Pediatr Infect Dis. 1984 May-Jun;3(3):272-80. Review. No abstract available.

PMID:
6377259
30.

An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin.

Hetherington SV, Spitznagel JK, Quie PG.

J Immunol Methods. 1983 Dec 16;65(1-2):183-90.

PMID:
6317755
31.

Sarcoidosis in children.

Hetherington SV.

Compr Ther. 1982 Oct;8(10):63-8. No abstract available.

PMID:
7140203

Supplemental Content

Loading ...
Support Center